Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk
GlobeNewswire
· *After five years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected..